| Literature DB >> 21410197 |
Thomas-Xavier Métro1, Anne Cochi, Domingo Gomez Pardo, Janine Cossy.
Abstract
SSR 241586 is a 2,2-disubstituted morpholine, developed by Sanofi-Aventis, which is active in the treatment of schizophrenia and irritable bowel syndrome (IBS). Different strategies have been studied to synthesize this molecule and among the strategies an organo-catalyzed Henry reaction, applied to an α-keto ester, has produced SSR 241586 in excellent enantiomeric excess.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21410197 DOI: 10.1021/jo102471r
Source DB: PubMed Journal: J Org Chem ISSN: 0022-3263 Impact factor: 4.354